Business
GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases
GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases\nCanada NewsWire\nLAS VEGAS, Dec. 7, 2018\n\n\n\nAs a Public Institution of Higher Education, the LSU AgCenter's public/private partnership with GB Sciences represents a first in the therapeutic cannabis industry\n LAS VEGAS, Dec. 7, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) announces on November 19, 2018, the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, on behalf of the Louisiana State University Agricultural Center, entered into a Master Research and Development Agreement with GB Sciences Louisiana, LLC. The Master Research and Development Agreement comes from the parties' desire to participate in joint research and development projects arising out of the production of therapeutic cannabis in Louisiana. As a public institution of higher education, the LSU AgCenter's public-private partnership with GB Sciences Louisiana represents a first in the therapeutic cannabis industry.\n\nThrough a competitive public bid process, the LSU AgCenter selected GB Sciences Louisiana, a subsidiary of GB Sciences, Inc., as its public-private partner to cultivate and produce therapeutic cannabis products for patients with specific medical conditions in Louisiana. GB Sciences, Inc., is a cannabis company focused on biopharmaceutical development, and has filed patent applications for use of cannabis therapies with neurodegenerative disease, chronic pain and heart therapies, as well as arthritis, Crohn's disease, inflammatory bowel disease and asthma.\nThe LSU AgCenter is one of two licensees in Louisiana approved to operate a Therapeutic Cannabis Program. In addition to the cultivation...